![Western Blot: Neuropilin-2 Antibody [NBP1-32241] - Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with Neuropilin-2 antibody [N2N3] (NBP1-32241) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/nbp1-32241_rabbit-polyclonal-neuropilin-2-antibody-910202419593551.jpg "Western Blot: Neuropilin-2 Antibody [NBP1-32241] - Whole cell extract (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with Neuropilin-2 antibody [N2N3] (NBP1-32241) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
| Reactivity | Hu, Mu, Rt, BvSpecies Glossary |
| Applications | WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Immunogen | Recombinant protein encompassing a sequence within the center region of human Neuropilin-2. The exact sequence is proprietary. |
| Localization | Membrane, Single-pass type I membrane protein |
| Predicted Species | Mouse (95%), Rat (95%), Bovine (97%). Backed by our 100% Guarantee. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | NRP2 |
| Purity | Antigen Affinity-purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
|
| Theoretical MW | 105 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
|
| Publications |
|
| Storage | Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
| Buffer | 0.1M Tris (pH 7), 0.1M Glycine, 10% Glycerol |
| Preservative | 0.01% Thimerosal |
| Purity | Antigen Affinity-purified |
![Immunohistochemistry Neuropilin-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Neuropilin1_AF566_Immunohistochemistry_21496.jpg)
![Immunohistochemistry Neuropilin-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Neuropilin1_AF566_Immunohistochemistry_21497.jpg)
![Western Blot Neuropilin-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Neuropilin1_AF566_Western_Blot_21557.jpg)
![Neutralization VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Block_Neutralize_1519.jpg)
![Immunohistochemistry VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Immunohistochemistry_22159.jpg)
![Immunohistochemistry VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Immunohistochemistry_6888.jpg)
| Publication using NBP1-32241 | Applications | Species |
|---|---|---|
| Roth L, Agemy L, Kotamraju VR et al. Transtumoral targeting enabled by a novel neuropilin-binding peptide. Oncogene. 2011-12-19 [PMID: 22179825] |
Secondary Antibodies |
Isotype Controls |
Research Areas for Neuropilin-2 Antibody (NBP1-32241)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![N/A VEGF [HRP]](https://images.novusbio.com/images2/DATA_VEGF_DVE00_ELISA_871.jpg)
![N/A VEGF [HRP]](https://images.novusbio.com/images2/DATA_VEGF_DVE00_ELISA_872.jpg)
![N/A VEGF [HRP]](https://images.novusbio.com/images2/VEGF_DVE00_ELISA_208.jpg)
![Semaphorin 3F [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "Semaphorin 3F [Unconjugated]")
![Bioactivity Semaphorin 3A [Unconjugated]](https://images.novusbio.com/images2/Semaphorin_3A_1250S3_1473.jpg)
![Immunohistochemistry VEGFR1/Flt-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R1_AF321_Immunohistochemistry_6778.jpg)
![Immunohistochemistry VEGFR1/Flt-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R1_AF321_Immunohistochemistry_9337.jpg)
![Western Blot VEGFR1/Flt-1 Antibody [Unconjugated]](https://images.novusbio.com/images/af321_human-vegf-r1-flt-1-affinity-purified-polyclonal-ab-8220249511449.jpg)
![N/A VEGF-C [HRP]](https://images.novusbio.com/images2/VEGF-C_DVEC00_ELISA_209.jpg)
![N/A VEGF-C [HRP]](https://images.novusbio.com/images2/DATA_VEGFC_DVEC00_ELISA_873.jpg)
![N/A VEGF-C [HRP]](https://images.novusbio.com/images2/DATA_VEGFC_DVEC00_ELISA_874.jpg)
![Flow Cytometry VEGFR3/Flt-4 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R3_AF743_Flow_Cytometry_15754.jpg)
![Immunocytochemistry/ Immunofluorescence VEGFR3/Flt-4 Antibody [Unconjugated]](https://images.novusbio.com/images/af743_mouse-vegf-r3-flt-4-affinity-purified-polyclonal-ab-41202410325571.jpg)
![Immunocytochemistry/ Immunofluorescence VEGFR3/Flt-4 Antibody [Unconjugated]](https://images.novusbio.com/images/af743_mouse-vegf-r3-flt-4-affinity-purified-polyclonal-ab-41202410325534.jpg)
![Immunohistochemistry Semaphorin 6A Antibody [Unconjugated]](https://images.novusbio.com/images/antibody/af1615_mouse-semaphorin-6a-affinity-purified-polyclonal-ab-immunohistochemistry-92202314926.jpg)
![Immunohistochemistry Plexin A3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Plexin_A3_AF4075_Immunohistochemistry_11308.jpg)
![Immunohistochemistry Plexin A3 Antibody [Unconjugated]](https://images.novusbio.com/images2/af4075_mouse-rat-plexin-a3-affinity-purified-polyclonal-ab-immunohistochemistry-1642021131527.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")